Form 4: Quest Diagnostics SVP, Clinical Solutions, Karthik Kuppusamy, Reports Stock Disposition for Tax Obligations
SEC Form 4 Filing
Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, reported the disposition of 74 shares of common stock to cover tax withholding obligations from vesting restricted share units on August 14, 2024.
Summary
- On August 14, 2024, Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, disposed of 74 shares of common stock.
- The disposition was to cover tax withholding obligations arising from the vesting of restricted share units.
- The price per share was $149.46.
- Following the transaction, Kuppusamy directly owns 13,449 shares of common stock.
- Kuppusamy also indirectly owns 358 shares via a trust and 1,557 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a neutral filing related to routine stock transactions for tax purposes and does not indicate any positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure related to insider transactions and is a common occurrence for executives at publicly traded companies. It provides transparency into the trading activities of company insiders.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of stock disposition to cover tax withholding obligations. |
| 08/16/2024 | Date of signature by Sean D. Mersten, Attorney in Fact for Karthik Kuppusamy. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.